|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61P 37/02 | (2006.01) |
| (11) | Number of the document | 3903829 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21178798.1 |
| Date of filing the European patent application | 2009-12-02 | |
| (97) | Date of publication of the European application | 2021-11-03 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-03 |
| (46) | Date of publication of the claims translation | 2023-06-12 |
| (30) | Number | Date | Country code |
| 207890 P | 2009-02-13 | US |
| (72) |
GOVINDAN, Serengulam , US
MOON, Sung-Ju , US
GOLDENBERG, David M , US
|
| (73) |
Immunomedics, Inc.,
c/o Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imunokonjugatai su viduląsteliniu būdu skaldoma jungtimi |
| IMMUNOCONJUGATES WITH AN INTRACELLULARLY-CLEAVABLE LINKAGE |
| Payment date | Validity (years) | Amount | |
| 2025-10-23 | 17 | 347.00 EUR |
| 2026-12-02 |